Personnel Information

写真a

GEN Yasuyuki


Job title

Assistant Professor

Graduating School 【 display / non-display

  • Kyoto Prefectural University of Medicine, Faculty of Medicine, Graduated

Graduate School 【 display / non-display

  • Kyoto Prefectural University of Medicine, Graduate School, Division of Medicine, Doctor's Course, Completed

Campus Career 【 display / non-display

  • 2016.11
    -
    Now
    Tokyo Medical and Dental University, Medical Research Institute, Medical Genomics, Molecular Cytogenetics, Assistant Professor

External Career 【 display / non-display

  • 2010.04
    -
    2016.10
    , Assistant Professor

Research Areas 【 display / non-display

  • Tumor therapeutics

Qualification Acquired 【 display / non-display

  • Doctor

 

Published Papers & Misc 【 display / non-display

  • Takagawa Yuki, Gen Yasuyuki, Muramatsu Tomoki, Tanimoto Kousuke, Inoue Jun, Harada Hiroyuki, Inazawa Johji. miR-1293, a Candidate for miRNA-Based Cancer Therapeutics, Simultaneously Targets BRD4 and the DNA Repair Pathway MOLECULAR THERAPY. 2020.06; 28 (6): 1494-1505. ( PubMed, DOI )

  • 寺崎 慶, 玄 泰行, 岩井 直人, 曽田 智大, 安居 幸一郎. 食道扁平上皮癌はSOX2/AKT/GSK3βシグナルを介してアポトーシス抵抗性を獲得する(Acquired resistance to apoptosis through the SOX2/AKT/GSK3β signaling pathway in esophageal squamous cell carcinoma) 日本癌学会総会記事. 2019.09; 78回 P-3293. ( ichushi )

  • 高川 祐希, 玄 泰行, 村松 智輝, 原田 浩之, 稲澤 譲治. 機能的miRNAライブラリースクリーニングによる、BRD4を標的とする新規癌抑制型miRNAの同定(Function-based microRNA library screening identified novel tumor suppressive microRNAs targeting BRD4) 日本癌学会総会記事. 2019.09; 78回 P-1238. ( ichushi )

  • 玄 泰行, 村松 智輝, 井上 純, 稲澤 譲治. 新規癌抑制型miRNAによるMYC標的核酸抗癌治療の可能性(Oligonucleotide therapeutics using a novel tumor-suppressive microRNA targeting MYC pathway) 日本癌学会総会記事. 2019.09; 78回 P-3226. ( ichushi )

  • 劉 暢, 玄 泰行, 稲澤 譲治. miR-3140はBRD4-MYCN経路を標的とし、神経芽腫細胞の増殖を抑制する(miR-3140 suppressed tumor cell growth in neuroblastoma by targeting BRD4-MYCN pathway) 日本癌学会総会記事. 2019.09; 78回 P-3228. ( ichushi )

display all >>

Conference Activities & Talks 【 display / non-display

  • Oligonucleotide therapeutics using a novel tumor-suppressive microRNA targeting MYC pathway. 2020.10.01

  • Yasuyuki Gen, Tomoki Muramatsu, Jun Inoue, Johji Inazawa. Oligonucleotide therapeutics using a novel tumorsuppressive microRNA targeting MYC pathway. 2019.09.28